ESR1 and breast cancer: Differences in tCho have been found to have predictive value for the 5-year survival of breast cancer patients receiving neoadjuvant chemotherapy (31) and higher choline concentrations have been found in core needle biopsies from patients that are ER- and/or PgR-negative compared to ER- and/or PgR-positive patients (10).